Product shipped from new production lines

RNS Number : 4921J
CAP-XX Limited
22 December 2020
 

 

 

 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

 

22 December 2020

 

CAP-XX Limited

("CAP-XX" the "Company")

 

Product shipped from new production lines

 

 

CAP-XX Limited, a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems, is pleased to announce that it has made its first customer shipments of supercapacitors from its new production lines at the newly constructed headquarters facility at Seven Hills, Sydney.

 

The production of these products, to the customers' requirements, follows the successful installation of the former Murata production lines previously announced.  The board is also pleased to report that the level of customer enquiries and sales orders continues to increase.

 

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer)  +61 (0) 2 9428 0139

 

Kreab (Financial PR)

Robert Speed  +44 (0) 20 7074 1800

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Alex Brearley  +44 (0) 20 3328 5656

 

 

More information is available at www.cap-xx.com

 

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQLLBLBLLXFBD
UK 100

Latest directors dealings